152 related articles for article (PubMed ID: 21133834)
21. Urinary concentration of monocyte chemoattractant protein-1 in idiopathic glomerulonephritis: a long-term follow-up study.
Tofik R; Ohlsson S; Bakoush O
PLoS One; 2014; 9(1):e87857. PubMed ID: 24489972
[TBL] [Abstract][Full Text] [Related]
22. Predictive value of urinary micro-cholesterol (mCHO) levels in patients with progressive glomerular disease.
Hotta O; Sugai H; Kitamura H; Yusa N; Taguma Y
Kidney Int; 2004 Dec; 66(6):2374-81. PubMed ID: 15569329
[TBL] [Abstract][Full Text] [Related]
23. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
24. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
[TBL] [Abstract][Full Text] [Related]
25. New insight into solvent-related end-stage renal disease: occupations, products and types of solvents at risk.
Jacob S; Héry M; Protois JC; Rossert J; Stengel B
Occup Environ Med; 2007 Dec; 64(12):843-8. PubMed ID: 17567724
[TBL] [Abstract][Full Text] [Related]
26. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
[TBL] [Abstract][Full Text] [Related]
27. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
Iseki K; Kinjo K; Iseki C; Takishita S
Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
[TBL] [Abstract][Full Text] [Related]
28. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
[TBL] [Abstract][Full Text] [Related]
29. Children presenting with end-stage renal disease of unexplained etiology: implications for disease recurrence after transplantation.
Butani L
Pediatr Transplant; 2006 Jun; 10(4):487-90. PubMed ID: 16712608
[TBL] [Abstract][Full Text] [Related]
30. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
31. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
[TBL] [Abstract][Full Text] [Related]
32. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
Bazzi C; Rizza V; Paparella M; Casellato D; Napodano P; Olivieri G; D'Amico G
J Nephrol; 2009; 22(3):387-96. PubMed ID: 19557716
[TBL] [Abstract][Full Text] [Related]
33. Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.
Heras M; Fernández-Reyes MJ; Sánchez R; Guerrero MT; Molina A; Rodríguez MA; Alvarez-Ude F
Nefrologia; 2012 May; 32(3):300-5. PubMed ID: 22508140
[TBL] [Abstract][Full Text] [Related]
34. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
[TBL] [Abstract][Full Text] [Related]
35. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
[TBL] [Abstract][Full Text] [Related]
37. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
38. Predictors of poor renal outcome in patients with biopsy-proven lupus nephritis.
Ayodele OE; Okpechi IG; Swanepoel CR
Nephrology (Carlton); 2010 Jun; 15(4):482-90. PubMed ID: 20609103
[TBL] [Abstract][Full Text] [Related]
39. [Clinical course and prognostic factors in lupus nephropathy].
Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
[TBL] [Abstract][Full Text] [Related]
40. [Selected markers of subclinical renal damage in men occupationally exposed to mercury vapours].
Rutowski J; Moszczyński P
Przegl Lek; 2006; 63 Suppl 7():65-73. PubMed ID: 17784548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
